CompanyGraph
At a glance
- Depends onMidstream position: 6 outgoing, 8 incoming connections
- FinancialsAltman Z-Score 11.03: safe zone
- Interpretations2 currently firing — 2
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.58%Below 5Y avg (1.02%)
Annual Rate
CNY 0.08Paid annual
Payout Ratio
34.0%Sustainable
Last Ex-Dividend
May 12, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
3.99BCNY591.99M · vs all stocks (USD)
Trailing P/E
56.69xvs Medical Devices peers
Revenue (TTM)
575.66MCNY85.50M · vs all stocks (USD)
Profit Margin
12.92%vs Medical Devices peers
Beta
0.0130xvs all stocks
52-Week Change
-5.72%vs all stocks
Market Capitalization
3.99BCNY591.99M · vs all stocks (USD)
Enterprise Value
3.63BCNY538.71M · vs all stocks (USD)
Trailing P/E
56.69xvs Medical Devices peers
Forward P/E
49.13xvs Medical Devices peers
Price to Sales (TTM)
7.37xvs Medical Devices peers
Price to Book (MRQ)
3.42xvs Medical Devices peers
Enterprise to Revenue
6.30xvs Medical Devices peers
Enterprise to EBITDA
43.26xvs Medical Devices peers
Gross Margin
49.92%vs Medical Devices peers
Profit Margin
12.92%vs Medical Devices peers
Operating Margin
11.90%vs Medical Devices peers
Return on Assets (TTM)
2.78%vs Medical Devices peers
Return on Equity (TTM)
6.11%vs Medical Devices peers
Revenue (TTM)
575.66MCNY85.50M · vs all stocks (USD)
Revenue per Share (TTM)
1.98CNYUpdated Aug 19, 2026Quarterly Revenue Growth
-6.90%vs Medical Devices peers
Gross Profit (TTM)
298.11MCNY44.27M · vs all stocks (USD)
EBITDA (TTM)
86.51MCNY12.85M · vs all stocks (USD)
Net Income (TTM)
74.37MCNY11.05M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-56.20%vs Medical Devices peers
Operating Cash Flow (TTM)
84.03MCNY12.48M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
21.99MCNY3.27M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.0800CNYUpdated Aug 19, 2026Trailing Annual Dividend Yield
0.58%vs all stocks
5-Year Average Dividend Yield
1.02%vs all stocks
Payout Ratio
34.00%vs Medical Devices peers
Revenue
584.03MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
270.87MCNYFY2025 · Dec 31, 2025Gross Profit
313.16MCNYFY2025 · Dec 31, 2025Operating Income
81.47MCNY12.10M · vs all stocks (USD)
Pre-tax Income
98.66MCNYFY2025 · Dec 31, 2025Income Tax Expense
11.60MCNYFY2025 · Dec 31, 2025Net Income
87.05MCNYFY2025 · Dec 31, 2025EBIT
99.09MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
126.29MCNYFY2025 · Dec 31, 2025Research & Development
60.43MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
92.06MCNYFY2025 · Dec 31, 2025Other Operating Expenses
7.11MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
12.31MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
428.89KCNYFY2025 · Dec 31, 2025EPS (Basic)
0.3000CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.3000CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
290.18MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
290.18MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
87.05MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
51.81MCNYFY2025 · Dec 31, 2025Free Cash Flow
-2.79MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
437.91MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
87.05MCNYFY2025 · Dec 31, 2025Other Non-cash Items
9.44MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-25.97MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-18.71MCNYFY2025 · Dec 31, 2025Capital Expenditures
-54.60MCNYFY2025 · Dec 31, 2025Sale of Investments
16.39MCNYFY2025 · Dec 31, 2025Other Investing Activity
88.68MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
50.47MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-25.06MCNYFY2025 · Dec 31, 2025Other Financing Charges
-3.44MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-28.50MCNYFY2025 · Dec 31, 2025Shares Outstanding
288.00MSharesUpdated Aug 19, 2026Float Shares
95.66MSharesUpdated Aug 19, 2026% Held by Insiders
67.33%vs all stocks
% Held by Institutions
0.92%vs all stocks
Total Cash (MRQ)
624.03MCNY92.68M · vs all stocks (USD)
Total Cash per Share (MRQ)
2.17CNYUpdated Aug 19, 2026Total Debt (MRQ)
6.07MCNY901.77K · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0049xvs Medical Devices peers
Current Ratio (MRQ)
4.48xvs Medical Devices peers
Book Value per Share (MRQ)
4.31CNYUpdated Aug 19, 2026Total Assets
1.49BCNY221.56M · vs all stocks (USD)
Total Current Assets
934.68MCNYFY2025 · Dec 31, 2025Total Liabilities
258.79MCNYFY2025 · Dec 31, 2025Total Non-current Assets
557.09MCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
6.97MCNYFY2025 · Dec 31, 2025Total Current Liabilities
251.82MCNYFY2025 · Dec 31, 2025Cash
437.89MCNYFY2025 · Dec 31, 2025Cash Equivalents
45.94MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
483.83MCNYFY2025 · Dec 31, 2025Other Short-term Investments
165.06MCNYFY2025 · Dec 31, 2025Accounts Receivable
43.98MCNYFY2025 · Dec 31, 2025Inventory
201.32MCNYFY2025 · Dec 31, 2025Accounts Payable
170.87MCNYFY2025 · Dec 31, 2025Short-term Debt
2.94MCNYFY2025 · Dec 31, 2025Other Current Liabilities
1.07MCNYFY2025 · Dec 31, 2025Long-term Debt
3.07MCNYFY2025 · Dec 31, 2025Common Stock (Book)
288.00MCNYFY2025 · Dec 31, 2025Retained Earnings
670.59MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
1.23BCNY183.12M · vs all stocks (USD)
52-Week Low
8.89CNYUpdated Aug 19, 202652-Week High
16.95CNYUpdated Aug 19, 202652-Week Change
-5.72%vs all stocks
Beta
0.0130xvs all stocks
50-Day MA
9.82CNYUpdated Aug 19, 2026200-Day MA
12.20CNYUpdated Aug 19, 2026Avg 10-Day Volume
10.21MSharesUpdated Aug 19, 2026Avg 30-Day Volume
5.77MSharesUpdated Aug 19, 2026Diluted EPS (TTM)
0.2600CNYUpdated Aug 19, 20262 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
Multi-Year Debt Decrease With Cash Near Total Debt And Equity
Long-term debt down in each of four years, and cash now covers most or all of what is left.
Reads
How is this stock valued?
High Retained Earnings With Profitability And Equity
Profits kept in the business fund much of what it owns, after five straight profitable years.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 11.03: safe zoneNotable
Altman Z-Score: 11.03
Supply Chain
Midstream position: 6 outgoing, 8 incoming connectionsNotable
Outgoing: 6.00Incoming: 8.00
High connectivity hub: 14 industry connectionsNotable
Total Connections: 14.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Nanjing Hicin Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
FDC Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Zhejiang Starry Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Shanghai Xiao Feng Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Cytek Biosciences, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Zhejiang Orient Gene Biotech Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Beijing Bohui Innovation Technology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
BrainsWay Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Nuvectis Pharma Inc.
Tier 1ProductionApproval-Gated PipelineRule
Zhuhai Rundu Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Companies that share active interpretations — structural patterns currently present in both stocks.
PC Connection, Inc.
2 interpretationsMulti-Year Debt Decrease With Cash Near Total Debt And EquityHigh Retained Earnings With Profitability And Equity
Sincere Navigation Corporation
2 interpretationsMulti-Year Debt Decrease With Cash Near Total Debt And EquityHigh Retained Earnings With Profitability And Equity
Samsung Electronics Co., Ltd.
2 interpretationsMulti-Year Debt Decrease With Cash Near Total Debt And EquityHigh Retained Earnings With Profitability And Equity